Hemophagocytic LymphohistiocytosisSymptoms, Doctors, Treatments, Advances & More
Hemophagocytic Lymphohistiocytosis Overview
Learn About Hemophagocytic Lymphohistiocytosis
- Familial hemophagocytic lymphohistiocytosis
- FHL
- Familial HLH
- Familial erythrophagocytic lymphohistiocytosis
- Familial histiocytic reticulosis
- HLH
ETSU Pediatrics- St. Jude's Clinic
Kim Nichols is a Hematologist and an Oncologist practicing medicine in Johnson City, Tennessee. Dr. Nichols is rated as an Elite provider by MediFind in the treatment of Hemophagocytic Lymphohistiocytosis. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Hemophagocytic Lymphohistiocytosis, Non-Langerhans-Cell Histiocytosis, Reticulohistiocytoma, Histiocytosis, and Bone Marrow Transplant. Dr. Nichols is board certified in American Board Of Pediatrics. Dr. Nichols is currently accepting new patients.
Franco Locatelli practices practicing medicine in Rome, Italy. Mr. Locatelli is rated as an Elite expert by MediFind in the treatment of Hemophagocytic Lymphohistiocytosis. He is also highly rated in 67 other conditions, according to our data. His clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Leukemia, Graft Versus Host Disease (GvHD), Bone Marrow Transplant, and Splenectomy.
Office
Carl Allen is a Hematologist and an Oncologist practicing medicine in Houston, Texas. Dr. Allen is rated as an Elite provider by MediFind in the treatment of Hemophagocytic Lymphohistiocytosis. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Langerhans Cell Histiocytosis, Reticulohistiocytoma, Histiocytosis, Hemophagocytic Lymphohistiocytosis, and Bone Marrow Transplant. Dr. Allen is currently accepting new patients.
Summary: Establishing a National Egyptian HLH Registry (NEHR)
Summary: This phase II trial tests the effects of ruxolitinib in combination with a de-intensified HLH-94 drug regimen has on patients with newly diagnosed hemophagocytic lymphohistiocytosis (HLH), a disorder caused by dysregulated immune responses (that is, immune responses that are too strong and cause inflammatory damage to normal tissues). The therapy used for HLH decreases the activity of the immune s...
Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center
